BRD4 and acute myeloid leukemia: Our study supports a model in which Brd4 increases the expression of Keap1, resulting in down-regulation of the Nrf2-antioxidant pathway and increases in both ROS levels and autophagy in NPMc+ AML cells [36, 37].